DISPENDIX Revenue and Competitors

The Dispendix organization was formed to commercialize a multi-award-winning non-contact acoustic nanoliter dispensing technology. For the very fast non-contact transfer of fluids, while increasing accuracy & precision, all without touching the liquids, the first product system is called I-DOT (“Immediate Drop on Demand technology”). I-DOT enables highly accurate, nearly dead volume free fluid transfer from 2 nl up to several microliters, while significantly reducing capital investment and running costs. I-DOT can dramatically enhance productivity and data quality plus the ability to easily handle complex, high combinatorial liquid handling tasks, such as for DNA Assembly in synthetic biology. The ability to dramatically enhance productivity and data quality plus the ability to easily handle complex, high combinatorial liquid handling tasks, such as for DNA Assembly in synthetic biology. Dispendix I-DOT platform is an ideal solution for applications in genomics, drug discovery and clinical research. Near future developments will be the technology for the use in cell line development or high precise volume determination. Dispendix is a part of the CELLINK group.